CEVR analyzes the benefits, risks, and costs of strategies to improve health and health care.

About Us
Data

News & Events

Recent Publications

Family spillover effects in pediatric cost-utility analyses

Applied Health Economics and Health Policy

Lavelle TA, D’Cruz BN, Mohit B, Ungar WJ, Prosser LA, Tsiplova K, Monserrat VL, Lin PJ. Family spillover effects in pediatric cost-utility analyses. Applied Health Economics and Health Policy 2018;

Future directions for cost-effectiveness analyses in health and medicine

Medical Decision Making

Neumann PJ, Kim DD, Trikalinos TA, Sculpher MJ, Salomon JA, Prosser LA, Owens DK, Meltzer DO, Kuntz KM, Krahn M, Feeny D, Basu A, Russell LB, Siegel JE, Ganiats TG, Sanders GD. Future Directions for Cost-effectiveness Analyses in Health and Medicine. Medical Decision Making 2018;38:767-77.

Comorbidity type and health care costs in type 2 diabetes: A retrospective claims database analysis

Diabetes Therapy

Lin P-J, Pope E, Zhou FL. Comorbidity type and health care costs in type 2 diabetes: A retrospective claims database analysis. Diabetes Therapy 2018;

The FDA’s new guidance on payer communications: Implications for real-world data and value-based contracts

Health Affairs Blog

Neumann PJ, Weissman H. "The FDA’s New Guidance On Payer Communications: Implications For Real-World Data And Value-Based Contracts," Health Affairs Blog, July 17, 2018.

Use and misuse of cost-effectiveness analysis thresholds in low- and middle-income countries: Trends in cost-per-DALY studies

Value Health

Leech AA, Kim DD, Cohen JT, Neumann PJ. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies. Value in Health 2018;21(7):759–61.

Specialty Drug Coverage Varies Across Commercial Health Plans In The US

Health Affairs

Chambers JD, Kim DD, Pope EF, Graff JS, Wilkinson CL, Neumann PJ. Specialty Drug Coverage Varies Across Commercial Health Plans In The US. Health Affairs 2018;37(7):1041–7.

Hemophilia burden of disease: A systematic review of the cost-utility literature for hemophilia

Journal of Managed Care & Specialty Pharmacy

Thorat T, Neumann PJ, Chambers JD. Hemophilia burden of disease: A systematic review of the cost-utility literature for hemophilia. Journal of Managed Care & Specialty Pharmacy 2018;24(7):632–42.

QALYs in 2018—Advantages and Concerns

JAMA

Neumann PJ, Cohen JT. QALYs in 2018—Advantages and Concerns. Jama 2018;319(24):2473.

Accelerating Alzheimer's disease drug innovations from the research pipeline to patients

Alzheimers & Dementia

Goldman DP, Fillit H, Neumann P. Accelerating Alzheimers disease drug innovations from the research pipeline to patients. Alzheimers & Dementia 2018;

Excluding patients from transplant due to social support: Results from a national survey of transplant providers

American Journal of Transplantation

Ladin K, Emerson J, Berry K, Butt Z, Gordon EJ, Daniels N, Lavelle TA, Hanto DW. Excluding patients from transplant due to social support: Results from a national survey of transplant providers. American Journal of Transplantation 2018;

Economic value of greater access to bariatric procedures for patients with severe obesity and diabetes

Medical Care

Kim DD, Arterburn DE, Sullivan SD, Basu A. Economic Value of Greater Access to Bariatric Procedures for Patients With Severe Obesity and Diabetes. Medical Care 2018;:1.

A comparison of coverage restrictions for biopharmaceuticals and medical procedures

Value in Health

Chambers J, Pope E, Bungay K, Cohen JT, Ciarametaro M, Dubois R, Neumann PJ. A comparison of coverage restrictions for biopharmaceuticals and medical procedures. Value in Health 2018;21(4):400–6.

Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes

British Journal of Haematolgy

Parsons SK, Kelly MJ, Cohen JT, Castellino SM, Henderson T, Kelly KM, Keller FG, Henzer TJ, Kumar AJ, Johnson P, Meyer RM, Radford J, Raemaekers J, Hodgson DC, Evens AM. Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes. Br J Haematol. 2018 Apr 29. doi: 10.1111/bjh.15255.

Accelerating Alzheimer's disease drug innovations from the research pipeline to patients

Alzheimer's & Dementia

Goldman DP, Fillit H, Neumann P. Accelerating Alzheimers disease drug innovations from the research pipeline to patients. Alzheimers & Dementia 2018;

Cost comparison across heart failure patients with reduced and preserved ejection fractions: Analyses of inpatient decompensated heart failure admissions

International Journal of Cardiology

Olchanski N, Vest A, Cohen JT, Neumann PJ, DeNofrio D. Cost Comparison Across Heart Failure Patients With Reduced And Preserved Ejection Fractions: Analyses Of Inpatient Decompensated Heart Failure Admissions. Journal of the American College of Cardiology 2018;67(13):1469.

The CEVR Team

Our team of experienced, dedicated researchers is led by health economists Peter Neumann and Josh Cohen. Together we produce cutting-edge health care cost-effectiveness research.

Meet the CEVR Team

Our Databases

Our comprehensive databases provide the information individuals and organizations need to analyze the benefits, risks, and costs of strategies to improve health and health care.